Health

Helius celebrates women’s leadership in the cannabis sector

Helius Therapeutics is taking time to look back on the day of suffrage. On September 19, 1893, New Zealand became the first country in the world to empower women.

128 years later, New Zealand has a third female prime minister. Almost half of parliamentarians are women. Female leaders also play an important role throughout the business sector, playing a leading role in science and healthcare.

Largest in Japan Licensed medical cannabis company, Helius Therapeutics is no exception. New Zealand’s first medical cannabis business Helius is a GMP license for manufacturing pharmaceuticals, but is led by the CEO. Carmen Doran.

“”Helius values ​​a variety of thoughts, backgrounds and experiences. This allowed us to build a strong team with a very good gender balance at all levels of the business. In addition, our sister company, Hale Animal Health, is led by Leila de Koster, “says Doran.

Recent Helius appointments include: Joanna Perry MNZM has been appointed to the Board of Directors and Mary Alice Simon has been appointed Chief Operating Officer.

A study showing that women make 80% of all health care decisions for their families shows that Helius, a woman, Wahine, is in New Zealand’s latest health journey where a local company is trying to make medical cannabis products. I am determined to make sure that it is an important part.

“Medical cannabis is also important because it’s only available by prescription. The workforce has undergone major changes in recent years, and new doctors are now mostly women,” she says.

Doran said it was an exciting time for New Zealand’s latest sector and opportunities for expansion, employment and exports were important.

“All industry players are working together to form our sector. Yes, we want to see more women leading the development of medical cannabis here in New Zealand. So far, gender When it comes to delegation, our sector is off to a good start, “she says.

Helius is focused on developing new, safe and effective treatments offered by an experienced team. Kiwi patients have long wanted access to high-quality, affordable local medical cannabis products. In the coming months, their patience will be rewarded.

Suffrage Day is only a few days after Helius announces a collaboration with Auckland University of Technology (AUT). Helius will work with AUT to research and develop advanced medical cannabis products.

“We are pleased to sponsor three AUT PhD students to work on the next generation of cannabis treatment. All three were women and it was not by design. Rather, all three A talented young woman, she has the passion for research and development that fits perfectly and is necessary to succeed for her patients, “says Doran.

Helius CEOs are often required to attend industry and healthcare events and speak at girls’ secondary school. More recently, this includes talking about the medical cannabis sector in a 12th grade agribusiness class at Columba College in Dunedin. Students are interested in future opportunities in the new industry.

“There is definitely a gender shift in STEM subjects, and more and more young women are studying science, technology, engineering, and math. Like doctors, more female scientists are now coming, but in New Zealand You have to keep it, “she says.

Doran is not a stranger in science of himself. He holds a master’s degree in biomedical engineering and a degree in mechanical engineering, and has 15 years of experience in the global pharmaceutical and veterinary pharmaceutical industry.

“Like Helius is building an R & D pipeline to offer new and exciting therapies, New Zealand needs to build a talent pipeline starting in elementary school. That’s how we keep the dials moving. “She says.

Last year, Helius announced the launch of a second innovative business. It is New Zealand’s first veterinary medical cannabis company.

The establishment of Hale Animal Health was driven by Leila de Koster, the company’s co-founder and managing director. The business is co-operated with Helius Therapeutics at its East Auckland headquarters.

“Hale is currently marketing premium supplement products made entirely from natural ingredients. Next, we move on to offering cannabis-focused products, including clinically proven veterinary drugs. It’s certainly an exciting and fast-moving sector, “says Msde Koster.

For Carmen Doran, diversity and inclusion include a variety of thoughts and experiences.

“Helios brings together people from a variety of backgrounds, from cannabinoid manufacturing and research to pharmaceutical systems and commerce. Diversity and inclusiveness provide the most innovative solutions for Kiwi patients and beyond. That’s the way, “she says.

Helius Therapeutics is a Foundation sponsor of the Med Can Summit 2022, which will be held at the Cordis Hotel in Auckland on February 10th and 11th next year.

www.helius.co.nz

Helius celebrates women’s leadership in the cannabis sector

Source link Helius celebrates women’s leadership in the cannabis sector

Back to top button